Malcolm Young awarded Ernst & Young Innovation Entrepreneur Of The Year 2010
News
e-Therapeutics partners with Cresset BioMolecular Discovery Ltd (“Cresset”) in drug discovery
Press Release 26 January 2009
Conditional investment in e-Therapeutics
Press Release 25 February 2009
e-Therapeutics raises £1,999,990 through a private placing and issue of Loan Notes, subject to the satisfaction of certain conditions.
Notice of General Meeting
Press Release 25 February 2009
Further to the announcement made earlier today, the Company confirms that a circular has now been dispatched to shareholders to convene a general meeting (“GM”) of the Company at 10.30 am on 16 March 2009 at the Company’s registered office, Holland Park, Holland Drive, Newcastle upon Tyne, NE2 4LZ.
Exclusive license agreement for India with Khandelwal Laboratories for 3 late-stage drug candidates
Press Release 24 February 2009
e-Therapeutics plc (AIM: ETX), the drug discovery and development company, today announces it has entered into an agreement with Khandelwal Laboratores Pvt. Ltd (KLAB), a specialist pharmaceutical company based in Mumbai, India.
Positive Phase IIa clinical trial of antidepressant ETS6103
Press Release: 14 January 2009
Patents granted for discovery technology in Europe, UK and India. Other territories expected to follow
Press Release: 11 November 2008
e-Therapeutics plc (AIM: ETX), the drug discovery and development company, is pleased to announce that it has been granted patent protection for its in silico drug discovery technology in Europe, the UK and India. The Company has also applied for protection in other territories, including the USA, and approvals are expected to follow shortly.